Drug Delivery Device with Dose Knob Clutch
Summary
The European Patent Office granted Sanofi-Aventis Deutschland GmbH Patent EP4360675A2 for a drug delivery device featuring a dose knob clutch mechanism. The patent, published March 25, 2026, covers innovations in injectable drug delivery technology designed for precise dose administration. Inventors Stefan Blancke and Axel Teucher developed the mechanism which enables controlled dose selection in pen-style injectors.
What changed
The EPO published European Patent Application EP4360675A2 for a drug delivery device incorporating a dose knob clutch. The clutch mechanism allows users to set and confirm medication doses while preventing accidental dose changes. This patent covers the mechanical design and operation of the dose setting assembly in drug delivery pens.
Pharmaceutical and medical device companies developing drug delivery systems should review this patent to assess potential freedom-to-operate implications. Competitors entering the pen injector market should evaluate whether their designs may infringe claims covered by this Sanofi patent. No immediate compliance actions are required as patents grant rights rather than impose regulatory obligations.
Source document (simplified)
DRUG DELIVERY DEVICE WITH DOSE KNOB CLUTCH
Publication EP4360675A2 Kind: A2 Mar 25, 2026
Applicants
Sanofi-Aventis Deutschland GmbH
Inventors
BLANCKE, Stefan, TEUCHER, Axel
IPC Classifications
A61M 5/315 20060101AFI20240524BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Medical Devices (A61M) publishes new changes.